In drug development, catalysts are used to improve the efficiency of chemical reactions involved in synthesizing active pharmaceutical ingredients (APIs). Catalysts can enhance the yield, selectivity, and rate of these reactions, making the drug production process more cost-effective and environmentally friendly. For SARS-CoV-2, catalytic processes are employed to synthesize antiviral compounds, optimize vaccine production, and develop diagnostic assays.